Dermatitis due to other substances taken internally
ICD-10 L27.8 is a billable code used to indicate a diagnosis of dermatitis due to other substances taken internally.
L27.8 refers to dermatitis due to other substances taken internally, which encompasses a range of skin reactions resulting from systemic exposure to various substances, including medications, supplements, and toxins. Clinically, patients may present with erythema, pruritus, and vesicular eruptions that can vary in severity. The anatomy involved primarily includes the skin and its appendages, where the inflammatory response manifests. Disease progression can vary, with some patients experiencing acute reactions that resolve upon discontinuation of the offending agent, while others may develop chronic dermatitis requiring ongoing management. Diagnostic considerations include a thorough patient history to identify potential exposures, physical examination findings, and, when necessary, patch testing or laboratory evaluations to rule out other dermatological conditions. Accurate diagnosis is crucial, as it informs treatment strategies and helps prevent future reactions.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L27.8 covers dermatitis caused by various substances taken internally, including but not limited to medications (e.g., antibiotics, NSAIDs), dietary supplements, and environmental toxins. It is essential to establish a clear link between the substance and the dermatitis through patient history and clinical evaluation.
L27.8 should be used when the dermatitis is specifically attributed to substances not classified under other codes, such as L27.0. If the substance is known and documented, L27.8 is appropriate for cases where the exact cause is less clear or involves multiple agents.
Documentation should include a detailed patient history outlining the substances taken, onset of symptoms, and any previous reactions. Clinical notes should describe the physical examination findings and any diagnostic tests performed to support the diagnosis of dermatitis due to internal substances.
